期刊文献+

癌基因c-erb B-2在结肠血吸虫病并发肠癌和肠息肉中的表达及AgNOR观察 被引量:1

EXPRESSION OF C ERB B 2 ONCOGENE AND OBSERVATION OF AgNOR ON COLONIC CANCER AND POLYP WITH CHRONIC COLONIC SCHISTOSOMIASIS
下载PDF
导出
摘要 目的:探讨肠道血吸虫病与肠癌发生的关系。方法:应用免疫组织化学LSAB法对结肠血吸虫病并发结肠癌、肠息肉和无血吸虫病的肠癌、肠息肉行cerbB2标记并AgNOR染色。结果:肿瘤细胞中癌基因cerbB2表达呈明显异质性;血吸虫病并发肠癌与无血吸虫病的肠癌表达阳性率,两者之间无明显差异(P>005);血吸虫病肠息肉的表达明显高于无血吸虫病的肠息肉(P<005)。血吸虫病肠息肉AgNOR/核均显著高于无血吸虫病的肠息肉(P<005);血吸虫病且cerbB2阳性肠息肉和无血吸虫病肠癌之间AgNOR/核均数无显著差异(P>005)。结论:肠癌中cerbB2阳性者具有较强浸润转移能力,血吸虫病肠息肉且cerbB2阳性者有癌前病变特征,血吸虫病肠息肉和并发肠癌恶性潜能高。 cases of colonic cancer and polyp with chronic colonic schistosomiasis and 20 cases of colonic cancer and polyp with non-schistosomiasis were labeled by C erb B 2 and stained by AgNOR. C erb B 2 positive rate of colonic cancer with schistosomiasis was 33 3% and 30 0% for non-schistosomasis. C erb B 2 positive rate of colonic polyp with schistosomiasis was 41 7% while 10% in non-schistosomiasis. The difference between two groups was highly significant (P<0 05) . Average of AgNOR nuclear particle of colonic polyp was 3 52±1 22 in schistosomiasis group and 2 47±0 89 in non-group (P<0 05) . It suggests that schistosome infection causes damage to colonic mucosa and stimulates grandular epithelium for proliferation. So, it presents highly latent malignancy.
出处 《九江医学》 1997年第2期67-70,共4页 Jiujiang Medical Journal
关键词 血吸虫病 肠肿瘤 肠息肉 癌基因 AGNOR colonic neoplasms colonic polyp schistosomiasis oncogene immunohistochemistry
  • 相关文献

同被引文献11

  • 1黄伟,刘惠敏.胃癌P53、P-糖蛋白的表达意义与肿瘤预后关系[J].实用诊断与治疗杂志,2005,19(4):240-241. 被引量:21
  • 2Zhang R, Takahashi S, Orita S, et al. p53 gene mutations in rectal cancer associated with schistosmiasis japonica in Chinese patients [J]. JCancerLett, 1998, 131(2):215.
  • 3Z Xu, D L Su. Schistosoma japonicum and colorectal cancer: an epidcmiological study in the People's Republic of China[J]. Int J Cancer, 1984, 34(3) :315.
  • 4Garkavt I, Kazarov A, Gudkov K, et al. Suppressiori of the novel growth inhibitor p33 ING1 promotes neoplastic transformation[J]. Nat Genet, 1996,4(1):425.
  • 5Hilton D A, West K P. c-erbB-2 oncogene product expression and prognosis in gastric carcinoma [J]. J Clin Pathol, 1992,45(5):455.
  • 6Wahib A A, Masoud A A, Halem A A, et al. Cell mediated immune response in chronic liver diseases: Schistosomal, viraland neoplastic[J]. J Egypt Soc Parasitol, 1998, 28(3):929.
  • 7Fallon P G, Richardson E J, Smith P, et al. Elevated type 1,diminished type 2 cytokines and impaired antibody response are associated with hepatotoxicity and mortalities during Schistoso ma mansoni infection of CD4- depleted mice[J]. Eur J Immunol,2000, 30(2):470.
  • 8Slaman D J, Clark G M, Wong S G, et al. Human breast cancer :correlation of relapse and survival with amplification of the HER-2/neu oncogen[J]. Science, 1987, 235 (6):177.
  • 9丁厚中,杨栋,吴福荣,李海,冯坤,郑斯杰,倪灿荣,于观贞.胃癌组织中p33^(ING1)基因的表达及突变的检测[J].中华医学杂志,2003,83(4):320-323. 被引量:16
  • 10陈凌,银平章,孔令非,刘正国.乳腺癌组织FHIT基因位点杂合性缺失及其蛋白表达的研究[J].实用诊断与治疗杂志,2004,18(2):109-112. 被引量:4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部